Review article: Problematic proctitis and distal colitis

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 20, Issue 4, 2004, Pages 93-96

  Gionchetti, P ^a,b   Rizzello, F ^a   Morselli, C ^a   Campieri, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETARSOL; AMINOSALICYLIC ACID; AZATHIOPRINE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CYCLOSPORIN; ENEMA; EPIDERMAL GROWTH FACTOR; FLUTICASONE; GLUCOCORTICOID; LIDOCAINE; MESALAZINE; NICOTINE; PREDNISOLONE 3 SULFOBENZOATE; PREDNISONE; SHORT CHAIN FATTY ACID; TIXOCORTOL PIVALATE;

CLINICAL TRIAL; COLITIS; COLON RESECTION; CROHN DISEASE; DISEASE COURSE; DISTAL COLITIS; DOSE RESPONSE; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG RESISTANCE; DRUG RESPONSE; ENDOCRINE DISEASE; FOAM; GEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTESTINE INFECTION; IRRITABLE COLON; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROCTITIS; REVIEW; SIDE EFFECT; SUPPOSITORY; ULCERATIVE COLITIS;

AMINOSALICYLIC ACIDS; CHRONIC DISEASE; COLITIS, ULCERATIVE; DRUG RESISTANCE; HUMANS; PROCTOCOLITIS; STEROIDS;

EID: 4844228367     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Farrokh-Yar F, Swarbrick ET, Grace RH, et al. Excellent outcome of first attack of ulcerative colitis in three regional cohorts. Gastroenterology 1999; 116: A711(Abstract).
2. Williams CN, Haber G, Aquino JA. Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active proctitis and measurement of extent of spread using 99m-Tc labelled 5-ASA suppositories. Dig Dis Sci 1987; 32: 71S-75S.
3. Jay M, Beihn RM, Digenis GA, et al. Disposition of radiolabelled suppositories in humans. J Pharm Pharmacol 1985; 37: 266-8.
4. Campieri M, Gionchetti P, Belluzzi A, et al. 5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis. J Clin Gastroenterol 1988; 10: 406-9.
5. Gionchetti P, Rizzello F, Venturi A, et al. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis. Dis Colon Rectum 1998; 41: 93-7.
6. Wilding IR, Kenyon CJ, Chauhan S, et al. Colonic spreading of a non-chlorofluorocarbon mesalazine rectal foam enema in patients with quiescent ulcerative colitis. Aliment Pharmacol Ther 1995; 9: 161-6.
7. van Bodegraven AA, Boer RO, Lourens J, Tuynman HA, Sindram JW. Distribution of mesalazine enemas in active and quiescent ulcerative colitis. Aliment Pharmacol Ther 1996; 10: 327-32.
8. Campieri M, Corbelli C, Gionchetti P, et al. Spread and distribution of 5-ASA colonic foam and 5-ASA enemas in patients with ulcerative colitis. Dig Dis Sci 1992; 37: 1890-7.
9. Gionchetti P, Venturi A, Rizzello F, et al. Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis. Aliment Pharmacol Ther 1997; 11: 679-84.
10. Campieri M, Paoluzi P, D'Albasio G, Brunetti G, Pera A, Barbara L. Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicentre comparative trial with 5-ASA enema. Dig Dis Sci 1993; 38: 1843-50.
11. Gionchetti P, Ardizzone S, Benvenuti ME, et al. A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled trial. Aliment Pharmacol Ther 1999; 13: 381-8.
12. Marshall JK, Irvine EJ. Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis. Aliment Pharmacol Ther 1995; 9: 293-300.
13. Marshall JK, Irvine EJ. Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Gut 1997; 40: 775-81.
14. Cohen RD, Woseth DM, Thisted RA, Hanauer SB. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol 2000; 95: 1263-76.
15. Sutherland LR, May GR, Shaffer EA. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993; 118: 540-9.
16. Safdi M, De Micco M, Sninsky C, et al. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. Am J Gastroenterol 1997; 92: 1867-71.
17. Meucci G, Vecchi M, Astegiano M, et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Am J Gastroenterol 2000; 95: 469-73.
18. Langholz E, Munkholm P, Davidsen M, Nielsen OH, Binder V. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 1996; 31: 260-6.
19. Marshall JK, Irvine EJ. Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Gut 1997; 40: 775-81.
20. Thiesen A, Thomson AB. Review article: older systemic and topical glucocorticosteroids and the gastrointestinal tract. Aliment Pharmacol Ther 1996; 10: 487-96.
21. Lofberg R, Ostergaard Thomsen O, Langholz E, et al. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Aliment Pharmacol Ther 1994; 8: 623-9.
22. Campieri M, Cottone M, Miglio F, et al. Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis. Aliment Pharmacol Ther 1998; 12: 361-6.
23. Campieri M, Adamo S, Valpiani D, et al. Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomized study. Aliment Pharmacol Ther 2003; 17: 1471-80.
24. Rizzello F, Gionchetti P, D'Arienzo A, et al. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2002; 16: 1109-16.
25. Baron JH. Outpatients treatment of ulcerative colitis. Br Med J 1962; 2: 441-4.
26. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults. Am J Gastroenterol 1997; 92: 204-11.
27. Patz J, Jacobsohn WZ, Gottschalk-Sabag S, Zeides S, Braverman DZ. Treatment of refractory distal ulcerative colitis with short-chain fatty acid enemas. Am J Gastroenterol 1996; 9: 731-4.
28. Sandborn WJ, Tremaine WJ, Leighton JA, et al. Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study. Aliment Pharmacol Ther 1997; 11: 663-71.
29. Pullan RD, Rhodes J, Ganesh S, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994; 330: 811-5.
30. Sandborn WJ, Tremaine WJ, Offord KP, et al. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomised. double-blind. placebo-controlled trial. Ann Intern Med 1997; 126: 364-71.
31. Connell AM, Lennard-Jones JE, Misiewicz JJ, et al. Comparison of acetarsol and prednisolone-21-phosphate suppositories in the treatment of idiopathic proctitis. Lancet 1965; I: 238-9.
32. Forbes A, Britton TC, House IM, Gazzard BG. Safety and efficacy of acetarsol suppositories in unresponsive proctitis. Aliment Pharmacol Ther 1989; 3: 553-6.
33. Bjork S, Dahlstrom A, Ahlman H. Topical treatment of ulcerative proctitis with lidocaine. Scand J Gastroenterol 1989; 24: 1061-72.
34. Sinha A, Nightingale J, West KP, Berlanga-Acosta J, Playford RJ. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med 2003; 349: 350-7.
35. Kirk AP, Lennard-Jones JE. Controlled trial of azathioprine in chronic ulcerative colitis. Br Med J 1982; 284: 1291-2.
36. Rosenberg JL, Wall AJ, Settles RH, et al. A controlled trial of azathioprine in the treatment of chronic ulcerative colitis. Gastroenterology 1973; 64: 793-801.